Indaptus Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Indaptus Therapeutics, Inc. reported Earnings Per Share Diluted of $21.58 (loss) per share for the year ending 2025.

  • Indaptus Therapeutics, Inc. showed an increase of +52.0% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Indaptus Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), Indaptus Therapeutics, Inc.'s Earnings Per Share Diluted has declined by 1,147.4%.
  • Historical annual values: Fiscal year 2025: $21.58 (loss) per share | Fiscal year 2024: $44.96 (loss) per share | Fiscal year 2023: $1.83 (loss) per share | Fiscal year 2022: $1.73 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: